GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (XBRU:ARGX) » Definitions » Other Liabilities for Banks

argenx SE (XBRU:ARGX) Other Liabilities for Banks


View and export this data going back to 2014. Start your Free Trial

What is argenx SE Other Liabilities for Banks?

Other Liabilities (Bank) only applies to banks.


argenx SE (XBRU:ARGX) Business Description

Industry
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.